Synergism between bioengineered miR‐34a prodrug and doxorubicin in suppressing osteosarcoma cell proliferation and xenograft tumor growthMei‐Juan Tu, Ai‐Ming Yu, Yifeng Yu et al.|The FASEB Journal|2016Cited by 0